MAR 28, 2020 7:21 AM PDT

FDA Approves 5-Minute Coronavirus Test

WRITTEN BY: Annie Lennon

In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change thanks to the FDA’s approval of a rapid-testing device by Abbott Laboratories capable of telling if someone is infected with the virus in just five minutes. 

John Frels, vice president of research and development at Abbott Diagnostics, said, “This is really going to provide a tremendous opportunity for front-line caregivers, those having to diagnose a lot of infections, to close the gap with our testing...A clinic will be able to turn that result around quickly, while the patient is waiting.”

To take the test, medical practitioners must take a swab from a patient’s nose or the back of their throat. Then mixing the swab in a chemical solution to break the virus down and release its RNA for identification, it is then inserted into an ID Now system, a box weighing less than 7 pounds. This box then identifies and reads select sequences relevant to the coronavirus genome. Taking just five minutes to deliver positive results when the patient has a high viral load, a more thorough analysis to rule out the virus altogether takes up to 13 minutes. 

Abbott Diagnostics has said that they will be able to make 50,000 of these tests per day from April 1st, and that they can be used in practically any healthcare setting. Thus, the US government initially plans on delivering them to where they are most needed- particularly in hospital emergency rooms, urgent-care clinics and doctors’ offices. 

This news comes after the FDA’s approval of Abbott’s m2000 RealTime system, another diagnostic technique that, although takes longer to produce results, can be produced at a much faster rate: up to 1 million tests per week. The two systems taken together mean that Abbott will soon be able to create at least 5 million tests per month. 

Meanwhile, other companies have also been working hard to deliver diagnostic tools for the coronavirus. Henry Schein Inc, for example, announced the availability of its point-of care antibody test. Looking for evidence that a person’s immune system has already fought off the virus, the blood test delivers results within 15 minutes, although it can’t be used to detect current infections. 


Sources: Bloomberg, Chicago Business and CNN 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
APR 15, 2020
Immunology
APR 15, 2020
Why More Men than Women Die from COVID-19
As of April 9th, over 60% of deaths from COVID-19 in New York state were men. Meanwhile, as of April 6, 82% of patients ...
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
APR 13, 2020
Drug Discovery & Development
APR 13, 2020
Experimental Drug Prevents Cancer Relapse
One of the main challenges of cancer treatments is preventing the cancer from returning again—in essence stopping ...
APR 23, 2020
Drug Discovery & Development
APR 23, 2020
Making Recombination-Protein Drugs Cost Effective
  In a study published in Nature Communications, scientists used genome-editing techniques to eliminate up to 70 pe ...
MAY 06, 2020
Cancer
MAY 06, 2020
Olanzapine useful for cancer patients managing nausea unrelated to chemo
A study published last week in JAMA Oncology reports that a generic drug called Olanzapine could be useful for cancer pa ...
MAY 10, 2020
Drug Discovery & Development
MAY 10, 2020
Antiviral Drug Treats Naso-Pharyngeal Cancer
Scientists at Hong Kong Baptist University (HKBU) developed a novel anti-Epstein-Barr virus (EBV) drug that can shrink t ...
Loading Comments...